Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ole Skouvig Pedersen1, Frauke Rudolf2, Isik Somuncu Johansen3

  • 1Lungesygdomme, Aarhus Universitetshospital.

Ugeskrift for Laeger
|March 6, 2024
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology and outcomes of urosepsis among admitted patients with urinary tract infections in Danish Emergency Departments: a retrospective cohort study.

Infectious diseases (London, England)·2026
Same author

Increased sensitivity of the updated FluoroType MTBDR V2 with addition of IS<i>6110</i> analysis.

Journal of clinical microbiology·2026
Same author

AdMiRE study: Development and validation of a WHO-aligned tool to assess healthcare access and antibiotic use among migrant populations in Europe-a multicountry Delphi and psychometric study on behalf of ESGITM group.

CMI communications·2026
Same author

Interferon-gamma release assay screening before solid organ transplantation in a low-incidence country: a prospective single-center cohort study.

Scientific reports·2026
Same author

Inhaled Corticosteroids and Non-Tuberculous Mycobacteria Risk in Patients with COPD.

Journal of clinical medicine·2026
Same author

Socioeconomic disparities and mortality among acute patients with sepsis: a retrospective Danish cohort study.

BMJ open·2026

Drug-resistant tuberculosis (DR-TB) is a growing global health threat. While new treatments show promise, ongoing challenges like emerging resistance necessitate continued drug development for tuberculosis.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Microbiology

Background:

  • Drug-resistant tuberculosis (DR-TB) presents a significant and increasing global health challenge.
  • Existing treatment regimens face limitations and evolving resistance patterns.

Approach:

  • This review synthesizes current data on the global epidemiology of DR-TB.
  • It examines the efficacy and limitations of novel treatment regimens.
  • Ongoing challenges and future research directions are discussed.

Key Points:

  • Novel regimens including bedaquiline, pretomanid, linezolid, and moxifloxacin offer new hope against DR-TB.
  • Emerging resistance to these new drugs, alongside other factors, remains a critical concern.
  • The global fight against DR-TB requires a sustained focus on developing new anti-tubercular agents.

Related Experiment Videos

Conclusions:

  • Despite advancements, the threat of DR-TB persists due to evolving resistance.
  • Continued innovation in drug discovery is crucial for overcoming the most resistant forms of tuberculosis.
  • A multi-faceted approach combining new drugs and epidemiological surveillance is vital.